(Reuters) – The U.S. Food and Drug Administration on Tuesday authorized a virtual reality (VR) system from Applied VR for reducing lower back pain after a majority of patients in a trial testing the device showed lesser discomfort.
The device, EaseVRx, uses cognitive behavioral therapy and other associated methods to help with pain reduction and is meant for self-use at home.
It consists of a VR headset and a controller, along with a breathing amplifier attached to the headset for use in deep breathing exercises. The treatment consists of 56 VR sessions, 2-16 minutes long, with an eight-week treatment program.
The device was authorized based on trial results that evaluated 179 patients, where about 65% of the patients showed a greater than 30% reduction in pain.
Software developer Applied VR has a number of virtual reality devices under development for diseases including anxiety and general pain.
Last year, a small study reut.rs/3ciPgsb suggested that immersion in virtual reality may relieve some of the pain of contractions before childbirth.
(Reporting by Dania Nadeem in Bengaluru; Editing by Vinay Dwivedi)